Literature DB >> 17454356

Poly(L-lactide-co-glycolide) nanospheres conjugated with a nuclear localization signal for delivery of plasmid DNA.

Oju Jeon1, Hee-Won Lim, Minhyung Lee, Su Jin Song, Byung-Soo Kim.   

Abstract

Polymeric nanospheres fabricated from biodegradable poly(lactide-co-glycolide) (PLGA) have been extensively investigated for applications in gene delivery. In this study, we show that the covalent conjugation of a nuclear localization signal (NLS, SV40 peptide) on PLGA nanospheres enhances the gene transfection efficiency. NLS conjugated PLGA copolymer was prepared by using a coupling reaction between maleimide-terminated PLGA copolymer and NLS in the presence of Imject maleimide conjugation buffer. PLGA nanospheres encapsulating plasmid (pDNA) were prepared by using a double emulsion-solvent evaporation method. The kinetics of in vitro release of pDNA from PLGA nanospheres was determined with UV in phosphate buffered saline (PBS). Gene transfection efficiency in human dermal fibroblasts was tested in vitro using nanospheres encapsulating the luciferase gene. The conjugation of the NLS peptide to the PLGA nanospheres could improve the nuclear localization and/or cellular uptake of PLGA nanosphere/pDNA constructs and thereby improve the transfection efficiency of a PLGA nanosphere gene delivery system. The pDNA was released from PLGA nanospheres over nine days. NLS conjugation enhanced the gene transfection efficiency in vitro by 1.2 approximately 3.2-fold over 13 days. PLGA/pDNA nanospheres appeared to be superior to PEI/pDNA complexes for the long-term expression of pDNA. Furthermore, the level of the sustained gene expression of the PLGA nanospheres was enhanced by the conjugation of NLS to the PLGA nanospheres. This study showed that the NLS conjugation enhanced the gene transfection efficiency of the PLGA nanosphere gene delivery system in vitro and that the enhanced gene expression was sustained for at least 13 days.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17454356     DOI: 10.1080/10611860601143479

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  11 in total

Review 1.  The pharmacology of regenerative medicine.

Authors:  George J Christ; Justin M Saul; Mark E Furth; Karl-Erik Andersson
Journal:  Pharmacol Rev       Date:  2013-07-01       Impact factor: 25.468

2.  Nanomedicine for gene therapy.

Authors:  Susan Muthe Alex; Chandra P Sharma
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

3.  Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery.

Authors:  Yichao Wang; Puwang Li; Lingxue Kong
Journal:  AAPS PharmSciTech       Date:  2013-03-06       Impact factor: 3.246

Review 4.  Polymeric vectors for ocular gene delivery.

Authors:  Viral Tamboli; Gyan P Mishra; Ashim K Mitrat
Journal:  Ther Deliv       Date:  2011-04

5.  Preparation and Characterization of Cationic PLA-PEG Nanoparticles for Delivery of Plasmid DNA.

Authors:  Weiwei Zou; Chunxi Liu; Zhijin Chen; Na Zhang
Journal:  Nanoscale Res Lett       Date:  2009-05-21       Impact factor: 4.703

6.  Efficient transfection of blood-brain barrier endothelial cells by lipoplexes and polyplexes in the presence of nuclear targeting NLS-PEG-acridine conjugates.

Authors:  Hongwei Zhang; Anton Mitin; Serguei V Vinogradov
Journal:  Bioconjug Chem       Date:  2009-01       Impact factor: 4.774

7.  Biodegradable tri-block copolymer poly(lactic acid)-poly(ethylene glycol)-poly(l-lysine)(PLA-PEG-PLL) as a non-viral vector to enhance gene transfection.

Authors:  Chunhua Fu; Xiaoli Sun; Donghua Liu; Zhijing Chen; Zaijun Lu; Na Zhang
Journal:  Int J Mol Sci       Date:  2011-02-23       Impact factor: 5.923

8.  Using inositol as a biocompatible ligand for efficient transgene expression.

Authors:  Lei Zhang; Susan L Bellis; Yiwen Fan; Yunkun Wu
Journal:  Int J Nanomedicine       Date:  2015-04-13

9.  Ligand-modified gene carriers increased uptake in target cells but reduced DNA release and transfection efficiency.

Authors:  Yen Cu; Cathy LeMoëllic; Michael J Caplan; W Mark Saltzman
Journal:  Nanomedicine       Date:  2009-10-02       Impact factor: 5.307

10.  Therapeutic Use of 3β-[N-(N',N'-Dimethylaminoethane) Carbamoyl] Cholesterol-Modified PLGA Nanospheres as Gene Delivery Vehicles for Spinal Cord Injury.

Authors:  So-Jung Gwak; Yeomin Yun; Do Heum Yoon; Keung Nyun Kim; Yoon Ha
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.